Clinical Trials
72
Active:3
Completed:22
Trial Phases
5 Phases
Phase 1:4
Phase 2:5
Phase 3:2
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (50 trials with phase data)• Click on a phase to view related trials
Not Applicable
33 (66.0%)Phase 4
6 (12.0%)Phase 2
5 (10.0%)Phase 1
4 (8.0%)Phase 3
2 (4.0%)Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy
Not Applicable
Not yet recruiting
- Conditions
- Amyloid Cardiomyopathy
- Interventions
- Drug: Enavogliflozin 0.3mgDrug: Placebo
- First Posted Date
- 2025-11-21
- Last Posted Date
- 2025-11-21
- Lead Sponsor
- Seoul St. Mary's Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT07240844
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, South Korea
🇰🇷Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery
Not Applicable
- Conditions
- Colorectal CancerPostoperative ComplicationUrinary Retention PostoperativeEnhanced Recovery After Surgery
- First Posted Date
- 2025-01-10
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Seoul St. Mary's Hospital
- Target Recruit Count
- 316
- Registration Number
- NCT06769087
- Locations
- 🇰🇷
Seoul St.Mary's hospital, the Catholic university of Korea, Seoul, Korea, Republic of
Comparison of Clinical Outcomes According to High-protein Provision in Critically Ill Patients After Abdominal Surgery
Not Applicable
Not yet recruiting
- Conditions
- Protein Malnutrition
- First Posted Date
- 2024-06-13
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- Seoul St. Mary's Hospital
- Target Recruit Count
- 152
- Registration Number
- NCT06458387
- Locations
- 🇰🇷
Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary's Hospital, Seoul, Seocho-gu, Banpo-dong Banpodaero 222, Korea, Republic of
The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy
Not Applicable
Not yet recruiting
- Conditions
- Pancreaticojuodenectomy
- Interventions
- Drug: The intravenous ferritin groupDrug: The placebo group
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Seoul St. Mary's Hospital
- Target Recruit Count
- 106
- Registration Number
- NCT06442111
A Clinical Feasibility Study of a Photoacoustic Finder
Active, not recruiting
- Conditions
- Breast CancerSentinel Lymph Node
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Seoul St. Mary's Hospital
- Target Recruit Count
- 129
- Registration Number
- NCT06412211
- Locations
- 🇰🇷
Seoul St. Mary's hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
No news found